Please login to the form below

Not currently logged in
Email:
Password:

Idea Pharma taps Astellas and Xention for new recruits

The phase II strategy consultancy appoints four new members of staff, including Astellas’ Amy Wasserman and Xention’s Calum Graham

Phase II strategy consultancy Idea Pharma has appointed four new members of staff, including Astellas' Amy Wasserman and Xention's Calum Graham.

Wasserman joins Idea Pharma as director of client value (US) after more than four years at Astellas Pharma US and before that stints at Janssen-Ortho and Solvay.

Meanwhile, Graham has over 20 years' pharma experience, including two years with Xention as director of business development. Prior to that he spent six years at GlaxoSmithKline leading global studies across a wide range of therapeutic areas.

Idea Pharma has also appointed Tristan Allen as European account manager and Claire Hales as office administrator (UK).

Allen was most recently an independent marketing and business development consultant while Hales joins Idea Pharma from the steel coating industry.

14th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics